Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 1 Mean serum thymidine kinase 1 (STK1) protein, STK1 activity levels and correlation between STK1 protein and activity in different groups

From: Breast and prostate cancer patients differ significantly in their serum Thymidine kinase 1 (TK1) specific activities compared with those hematological malignancies and blood donors: implications of using serum TK1 as a biomarker

   STK1 protein (ng/mL) STK1 activity (pmol/min/mL)   
   Mean ± SD (M) Mean ± SD (M)   
Tumor type N   rs* P
Myeloid dysplastic 22 19 ± 9.0 (19) 11 ± 17.5 (3) 0.63 0.0015
Syndrome (MDS)
Breast cancer 42 22 ± 11 (21) 6.7 ± 18.8 (1.8) 0.41 0.0077
Prostate cancer 47 20 ± 12 (22) 1.8 ± 1.4 (1.3) 0.45 0.0015
Healthy 30 5 ± 3.5 (4) 1.1 ± 0.6 (0.9) 0.49 0.0056
  1. *Spearman’s correlation coefficient.